Navigation Links
Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)

NEW YORK, Jan. 30, 2013 /PRNewswire/ -- Morgan & Morgan is investigating the Board of Directors of MAP Pharmaceuticals Inc. ("MAP" or the "Company") (Nasdaq: MAPP) for possible breaches of fiduciary duty and other violations of law related to the sale of the Company to Allergan Inc.

If you are a current shareholder of MAP and are interested in learning more about our MAP Pharmaceuticals merger investigation, please contact George Pressly, Esq. at 1 (800) 631-6234 or email George at

Under the terms of the transaction, MAP shareholders will receive $25 for each share of MAP stock they own. The transaction has a total approximate value of $958 million. The investigation concerns whether the MAP Board of Directors has breached its fiduciary duties to act in the best interests of MAP shareholders and to take all necessary steps to ensure that MAP shareholders receive the maximum value readily available for their shares of MAP common stock.

About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people." 

Attorney advertising. Prior results do not guarantee a similar outcome.

Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
Suite 2001
New York, NY  10036

SOURCE Morgan & Morgan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier / Gold Standards Kay Morgan Awarded NCPCP Highest Honor
2. Zimmer Holdings to Present at Morgan Stanley 2012 Global Healthcare Conference
3. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
4. Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
5. Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference
6. Hologic To Participate In The Morgan Stanley Global Healthcare Conference
7. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
8. Cyberonics To Present At Morgan Stanley 2012 Global Healthcare Conference
9. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
10. Depomed To Present At Morgan Stanley 2012 Healthcare Conference
11. Boston Scientific to Participate in the 2012 Morgan Stanley Global Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... 2015 Developmental, commercial, and regulatory/legal ... profitability of pharmaceutical products, says GBI Research ... regulatory/legal strategies all play a key role in boosting ... . --> Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ...
(Date:11/25/2015)... Research and Markets ( ) has ... Global Forecast to 2020" report to their offering. ... 37.21% of the total market share in 2014. The ... is projected to growth at the highest CAGR between ... to the fast growing water, industrial gas treatment, pharmaceutical, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted to ... raising public awareness of the disorder while helping to bring expert medical care ... to bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... to offer their patients the many benefits of the revolutionary BIOLASE WaterLase iPlus ... cutting and scraping tools traditionally used by a dentist in Gettysburg, PA ...
(Date:11/24/2015)... ... 24, 2015 , ... ThirdLove, the fast-growing bra company that ... offering 40% off select bras and underwear styles, now through Saturday, November 28th. ... technology and the latest fashion, quickly becoming the next generation of luxury bras. ...
(Date:11/24/2015)... ... 24, 2015 , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the ... , FDA has long asserted that design and manufacture of Laboratory Developed Tests ... do not meet the device regulations. , Come up short in an inspection and ...
(Date:11/24/2015)... ... November 24, 2015 , ... United Benefit Advisors (UBA), ... & Company as its newest Partner Firm. Based in Jefferson City, Missouri, their ... trusted advisor regardless of whether that client is a business, a family, or ...
Breaking Medicine News(10 mins):